Home /Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial

Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial

Submitted by dcc on Wed, 04/26/2023 - 10:07
TitleIntraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial
Publication TypeJournal Article
Year of Publication2023
AuthorsNagao, S, Fujiwara, K, Yamamoto, K, Tanabe, H, Okamoto, A, Takehara, K, Saito, M, Fujiwara, H, Tan, DSP, Yamaguchi, S, Adachi, S, Kikuchi, A, Hirasawa, T, Yokoi, T, Nagai, T, Sato, T, Kamiura, S, Fujishita, A, Loong, WWai, Chan, K, Syks, P, Olawaye, A, Ryu, S-Y, Shigeta, H, Kondo, E, Yokoyama, Y, Matsumoto, T, Hasegawa, K, Enomoto, T
JournalNEJM Evidence
Volume2
Issue5
Date PublishedJan-04-2025
ISSN2766-5526
URLhttps://evidence.nejm.org/doi/10.1056/EVIDoa2200225
DOI10.1056/EVIDoa2200225
Short TitleNEJM Evidence